Corporate Profile and Structure

Corporate Structure

Corporate structure as of December 31, 2018

The management structure of the Bayer Group comprises three divisions – Pharmaceuticals, Consumer Health and Crop Science – and the Animal Health business unit, which are also our reporting segments. The corporate functions, Business Services and the service company Currenta support the operational business.

Bayer Group Structure in 2018

Bayer Group Structure in 2018 (chart)

Pharmaceuticals concentrates on prescription products, especially for cardiology and women’s health care, and on specialty therapeutics focused on the areas of oncology, hematology and ophthalmology. The division also comprises the radiology business, which markets diagnostic imaging equipment together with the necessary contrast agents. Our portfolio includes a range of key products that are among the world’s leading pharmaceuticals for their indications. The prescription products from Pharmaceuticals are primarily distributed through wholesalers, pharmacies and hospitals.

Consumer Health is a leading supplier of nonprescription ( OTC (over-the-counter) designates the business with nonprescription medicines. = over-the-counter) medicines, medical products, cosmetics and other self-care solutions in the categories of dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, cough and cold, foot care and sun protection. The products are generally sold by pharmacies, supermarket and drugstore chains, online retailers and other large retailers.

Crop Science is the world’s leading agriculture enterprise following the acquisition of Monsanto, with businesses in crop protection and seeds. We offer a broad portfolio of high-value seeds, improved plant traits, innovative chemical and biological crop protection products, digital solutions and extensive customer service for sustainable agriculture. We market these products primarily via wholesalers and retailers or directly to farmers. In addition, we market pest and weed control products and services to professional users outside the agriculture industry. Most of our crop-protection products are manufactured at the segment’s own production sites. Numerous decentralized formulation and filling sites enable the company to quickly react to the needs of local markets. The breeding, propagation, production and / or processing of seeds, including seed dressing, takes place at locations close to our customers, either at our own facilities or under contract.

Animal Health is a global leader in its field. We develop innovative products and solutions for the prevention and treatment of diseases in companion and farm animals. We market our animal health products globally through veterinarians and other distribution channels such as pharmacies or retail stores.

The corporate functions and Business Services operate as Group-wide competence centers in which business support services are bundled. Currenta is the service company responsible for managing and operating the Chempark sites in Leverkusen, Dormagen and Krefeld-Uerdingen.

More information on the segments’ products and activities is contained in the following table:

Products and Activities of the Segments

Indication / Application / Business


Core activities and markets


Main products and brands1


The order of the products listed is no indication of their significance.








Hypertension, pulmonary hypertension, heart attack and stroke, thrombosis, coronary artery disease (CAD), peripheral artery disease (PAD)


Xarelto™, Adalat™, Aspirin™ Cardio, Adempas™



Liver cancer, renal cell carcinoma, thyroid carcinoma, prostate cancer, colorectal cancer, gastrointestinal stromal tumors (GIST), follicular lymphoma, solid tumors with NTRK gene fusions


Nexavar™, Xofigo™, Stivarga™, Aliqopa™, Vitrakvi™



Visual impairment due to age-related macular degeneration (AMD), diabetic macular edema (DME) or retinal vein occlusion (RVO)





Hemophilia A


Kogenate™ / Kovaltry™ / Jivi™

Women’s health


Contraception, gynecological therapy


Mirena™ product family, Yaz™ / Yasmin™ / Yasminelle™; Visanne™

Infectious diseases


Bacterial infections


Avalox™ / Avelox™, Cipro™, Ciprobay™



Contrast agents; diagnostic imaging equipment for use with contrast agents


Gadovist™, Ultravist™, Medrad Spectris Solaris™, Medrad Stellant™



Multiple sclerosis


Betaferon™ / Betaseron™

Consumer Health







Wound care, skin care, skin and intimate health


Bepanthen™, Canesten™



Multivitamin products, dietary supplements


One A Day™, Elevit™, Berocca™, Supradyn™, Redoxon™



General pain relief


Aspirin™, Aleve™

Digestive health


Digestive health complaints


MiraLAX™, Rennie™, Iberogast™






Cough and cold


Cough and cold


Aspirin™, Alka-Seltzer™, Afrin™

Foot care


Foot care


Dr. Scholl’s™

Sun protection


Sun protection



Crop Science







Chemical crop protection products to control weeds


Roundup™, Adengo™, Alion™, Corvus™, Atlantis™, Harness™, Warrant™

Corn Seed & Traits


Seeds and traits for corn


Dekalb™, SmartStax™ RIB Complete, VT Double™ PRO, VT Triple™ PRO

Soybean Seed & Traits


Seeds and traits for soybeans


Asgrow™, Intacta RR2PRO™ Roundup Ready 2 Xtend™, Roundup Ready 2 Yield™



Biological and chemical products to protect crop plants from fungal diseases


Flint™, Fox™, Luna™, Nativo™, Prosaro™, Serenade™, Xpro™



Biological and chemical products to protect crop plants from harmful insects and their larvae


BioAct™, Confidor™, Movento™, Sivanto™

Environmental Science


Products for professional pest control, vector control, forestry, golf courses and parks, railway tracks


Ficam™, Maxforce™, Esplanade™, K‑Othrine™

Vegetable Seeds


Vegetable seeds


Seminis™, DeRuiters™

Digital Agriculture


Digital applications for agriculture


Climate FieldView™



Seeds and traits for cotton, oilseed rape / canola, rice and wheat as well as biological and chemical seed treatment products to protect against fungal diseases and pests


Gaucho™, Bollgard™ II, Bollgard™ II XtendFlex™, Deltapine™

Animal Health





Companion animals business


Veterinary medicines and solutions to protect and maintain the health and wellbeing of companion animals, focusing on antiparasitics and anti-infectives


Advantage™ product family, Seresto™, Drontal™ product family, Baytril™

Farm animals business


Veterinary medicines and solutions to treat and prevent parasitic diseases, anti-infectives, immunostimulants, pharmacological treatments and farm hygiene products


Baytril™, Cydectin™

We operate sites around the world, and some are used by multiple segments. As of December 31, 2018, the Bayer Group comprised 420 consolidated companies in 90 countries.

Significant research and development location

Significant production location

Significant administrative site

Management functions of Bayer AG

As the parent company of the Bayer Group, Bayer AG – represented by its Board of Management – performs the principal management functions for the entire company. This mainly comprises the Group’s strategic alignment, resource allocation, and the management of financial affairs and managerial staff, along with the management of the Group-wide operational business of the segments. In addition, Bayer AG also performs the corresponding parent company functions for Pharmaceuticals and Crop Science in Germany.

Changes to the corporate structure

On June 7, 2018, Bayer completed the acquisition of the Monsanto Company, St. Louis, Missouri, United States (Monsanto), for US$63 billion, including debt. The divestments to BASF required to fulfill the antitrust conditions were completed on August 1, 2018, for all businesses earmarked for divestment excluding the vegetable seed business, which was divested as of August 16, 2018. The closing of these transactions led to the hold separate order being lifted and enabled the integration of Monsanto into the Bayer Group to begin.

See Chapter “Key Events” for further details of the Monsanto acquisition

See Chapter “About this Report” for information on reporting thresholds

In connection with the acquisition, the structure was adjusted as of the second quarter of 2018 to reflect the relative sizes of the various strategic business entities at that time and moving forward. Due to the relative sizes of the former Monsanto businesses “Corn seed and traits” and “Soybean seed and traits,” we now report our corresponding strategic business entities Corn Seed & Traits and Soybean Seed & Traits separately. The former Monsanto business “Agricultural Productivity” was allocated among Herbicides, Environmental Science and Other, while “Cotton seed and traits” and “All other crops seeds and traits” are reported under Other and the “Vegetable seeds” business was allocated to our Vegetable Seeds business entity. Due to its relative size, we no longer report our SeedGrowth business separately, but under Other. Regional reporting is not impacted by these changes. The figures for previous reporting periods have been adjusted accordingly.

A comparison of the Crop Science reporting structure in effect until December 31, 2017, and the reporting structure in effect since the second quarter of 2018 is shown in the following table.

Realigned Crop Science Structure

Reporting structure until Dec. 31, 2017


Reporting structure as of Dec. 31, 2018

Crop Protection / Seeds


Crop Protection






Corn Seed & Traits


Soybean Seed & Traits











Environmental Science


Environmental Science


Vegetable Seeds



Crop Science (total)


Crop Science (total)

The Monsanto business is included in full from the date the acquisition closed. The divestments to BASF are not included in the figures from the dates the transactions were completed. The reported portfolio effect on the sales of Crop Science (and of the Bayer Group) therefore includes the contribution from the Monsanto business since June 7, 2018, less the contribution of the divested businesses to Q3 2017 sales after August 1 and 16, respectively.

Compare to Last Year